When I first started writing about the industry, single use was considered the new kid on the block – and was subject to enormous scrutiny. Today, it’s an established part of biopharma drug manufacturing. In ‘Charting the Rise of Single Use’, biopharma experts remind us how attitudes to the technology have changed over the years. Below, you’ll also find content on potent drugs and why excipients may not be as inert as previously thought.
Until next time – Stephanie Sutton, Editor
 
BIOPROCESSING - SINGLE USE SYSTEMS
Charting the Rise of Single Use
08/20/2020 | Stephanie Vine
Single-use systems have come a long way. We look at experience with the technology so far.
DRUG DISCOVERY
The Natural Drug Factory
07/28/2020 | Maryam Mahdi
Solving a decades-old mystery, researchers have discovered how non-ribosomal peptide synthetases work.
INGREDIENTS
Getting a Handle on High Potency
08/01/2020 | Alyn McNaughton
We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.
INGREDIENTS
Biologically Active Excipients?
08/21/2020 | Maryam Mahdi
Newly published research suggests that some excipients may be more "active" than previously thought.
 
Webinar
Smart Shipping Solutions For Cell Therapy Logistics

Join The Medicine Maker and Cytiva on September 10 for a webinar on overcoming cell therapy logistics without the hazards of liquid nitrogen. Find out more
 
White Papers
Measurement of the concentration of Adeno-Associated Virus

For virus development and production, it is important to know the virus concentration at different stages of the process, to optimize the clone used as well as the production yields. Read more
Laboratory Powder X-ray Diffraction System used for Pharmaceutical Challenges

In the pharmaceutical industry, the detection of polymorph traces is one of the most important applications for powder X-ray diffraction. Read more
 
Special Promotion
The Cell + Gene Curator - a newsletter focused on the science of cell and gene therapies

Connecting you to discoveries, innovation, and business updates from the cell and gene therapy community. Learn more and subscribe
Uncover the World of Microbiome Science

The microbiome field offers huge potential. Find out why experts from across the pharma industry are excited about this emerging science, and how it could lead to new breakthrough medicines. More Information.
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.